LAMEA Conjunctivitis Treatment Market Size, Share & Trends Analysis Report By Disease Type, By Drug Class (Anti-allergic, Antiviral, Artificial Tears, and Antibiotics), By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa Conjunctivitis Treatment Market would witness market growth of 7.1% CAGR during the forecast period (2023-2030).

The conjunctivitis treatment market refers to the sector within the healthcare industry dedicated to addressing and providing therapeutic interventions for conjunctivitis, commonly known as pink eye. This market encompasses various pharmaceuticals, medical devices, and treatment modalities designed to alleviate symptoms and manage conjunctivitis, including those caused by viral, bacterial, allergic, or irritant factors. The market stakeholders include pharmaceutical companies, healthcare providers, ophthalmologists, and researchers. The market is characterized by ongoing research and development efforts to enhance treatment efficacy, minimize side effects, and introduce innovative solutions, contributing to improving patient outcomes.

In recent years, the conjunctivitis treatment market has witnessed significant advancements driven by rigorous research and development activities. Pharmaceutical innovations, coupled with a deeper understanding of the underlying causes of conjunctivitis, have introduced targeted treatment modalities. These innovations encompass a range of pharmaceutical options, including antibiotics for bacterial conjunctivitis, antivirals for viral forms, and anti-allergic medications for allergic conjunctivitis. Additionally, the market has seen the emergence of medical devices and eye drops designed to provide relief and facilitate a more rapid recovery.

According to the Ministry of Economy of UAE, healthcare expenditures in the UAE are expected to rise to $21.3 billion by 2021, which is projected to account for 4.6% of the country's GDP by 2026. A decade survey to estimate future spending indicates that healthcare spending will reach $26 billion by 2028. The UAE market boasts an average of $1,200 in healthcare spending per capita, placing the country in the top 20. Furthermore, medical tourism in the UAE is expected to grow to AED 14 billion by the end of 2021, and it could touch AED 19 billion by 2023. Therefore, the rising medical tourism and expansion of the region's healthcare sector are propelling the market's growth.

The Brazil market dominated the LAMEA Conjunctivitis Treatment Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $128.9 Million by 2030. The Argentina market is registering a CAGR of 7.6% during (2023 - 2030). Additionally, The UAE market would showcase a CAGR of 6.7% during (2023 - 2030).

Based on Disease Type, the market is segmented into Allergic Conjunctivitis, Viral Conjunctivitis, and Bacterial Conjunctivitis. Based on Drug Class, the market is segmented into Anti-allergic, Antiviral, Artificial Tears, and Antibiotics. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Novartis AG
Gilead Sciences, Inc.
GlaxoSmithKline PLC
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
AbbVie, Inc.
AFT Pharmaceuticals
Bausch Health Companies, Inc.
Teva Pharmaceutical Industries Ltd.

LAMEA Conjunctivitis Treatment Market Report Segmentation

By Disease Type

Allergic Conjunctivitis
Viral Conjunctivitis
Bacterial Conjunctivitis

By Drug Class

Anti-allergic
Antiviral
Artificial Tears
Antibiotics

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Conjunctivitis Treatment Market, by Disease Type
- 1.4.2 LAMEA Conjunctivitis Treatment Market, by Drug Class
- 1.4.3 LAMEA Conjunctivitis Treatment Market, by Distribution Channel
- 1.4.4 LAMEA Conjunctivitis Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Conjunctivitis Treatment Market, by Disease Type

4.1 LAMEA Allergic Conjunctivitis Market, by Country
4.2 LAMEA Viral Conjunctivitis Market, by Country
4.3 LAMEA Bacterial Conjunctivitis Market, by Country

Chapter 5. LAMEA Conjunctivitis Treatment Market, by Drug Class

5.1 LAMEA Anti-allergic Market, by Country
5.2 LAMEA Antiviral Market, by Country
5.3 LAMEA Artificial Tears Market, by Country
5.4 LAMEA Antibiotics Market, by Country

Chapter 6. LAMEA Conjunctivitis Treatment Market, by Distribution Channel

6.1 LAMEA Hospital Pharmacy Market, by Country
6.2 LAMEA Retail Pharmacy Market, by Country
6.3 LAMEA Online Pharmacy Market, by Country

Chapter 7. LAMEA Conjunctivitis Treatment Market, by Country

7.1 Brazil Conjunctivitis Treatment Market
- 7.1.1 Brazil Conjunctivitis Treatment Market, by Disease Type
- 7.1.2 Brazil Conjunctivitis Treatment Market, by Drug Class
- 7.1.3 Brazil Conjunctivitis Treatment Market, by Distribution Channel
7.2 Argentina Conjunctivitis Treatment Market
- 7.2.1 Argentina Conjunctivitis Treatment Market, by Disease Type
- 7.2.2 Argentina Conjunctivitis Treatment Market, by Drug Class
- 7.2.3 Argentina Conjunctivitis Treatment Market, by Distribution Channel
7.3 UAE Conjunctivitis Treatment Market
- 7.3.1 UAE Conjunctivitis Treatment Market, by Disease Type
- 7.3.2 UAE Conjunctivitis Treatment Market, by Drug Class
- 7.3.3 UAE Conjunctivitis Treatment Market, by Distribution Channel
7.4 Saudi Arabia Conjunctivitis Treatment Market
- 7.4.1 Saudi Arabia Conjunctivitis Treatment Market, by Disease Type
- 7.4.2 Saudi Arabia Conjunctivitis Treatment Market, by Drug Class
- 7.4.3 Saudi Arabia Conjunctivitis Treatment Market, by Distribution Channel
7.5 South Africa Conjunctivitis Treatment Market
- 7.5.1 South Africa Conjunctivitis Treatment Market, by Disease Type
- 7.5.2 South Africa Conjunctivitis Treatment Market, by Drug Class
- 7.5.3 South Africa Conjunctivitis Treatment Market, by Distribution Channel
7.6 Nigeria Conjunctivitis Treatment Market
- 7.6.1 Nigeria Conjunctivitis Treatment Market, by Disease Type
- 7.6.2 Nigeria Conjunctivitis Treatment Market, by Drug Class
- 7.6.3 Nigeria Conjunctivitis Treatment Market, by Distribution Channel
7.7 Rest of LAMEA Conjunctivitis Treatment Market
- 7.7.1 Rest of LAMEA Conjunctivitis Treatment Market, by Disease Type
- 7.7.2 Rest of LAMEA Conjunctivitis Treatment Market, by Drug Class
- 7.7.3 Rest of LAMEA Conjunctivitis Treatment Market, by Distribution Channel

Chapter 8. Company Profiles

8.1 Novartis AG
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Gilead Sciences, Inc.
- 8.2.1 Company overview
- 8.2.2 Financial Analysis
- 8.2.3 Research & Development Expenses
- 8.2.4 SWOT Analysis
8.3 GlaxoSmithKline PLC
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Trial and Approval
- 8.3.6 SWOT Analysis
8.4 F. Hoffmann-La Roche Ltd.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 SWOT Analysis
8.5 Merck & Co., Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Partnerships, Collaborations, and Agreements:
- 8.5.6 SWOT Analysis
8.6 Boehringer Ingelheim International GmbH
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional & Segmental Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
8.7 AbbVie, Inc.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
8.8 AFT Pharmaceuticals
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental Analysis
- 8.8.4 Research & Development Expenses
- 8.8.5 SWOT Analysis
8.9 Bausch Health Companies, Inc
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 Recent strategies and developments:
  - 8.9.5.1 Acquisition and Mergers:
- 8.9.6 SWOT Analysis
8.10. Teva Pharmaceutical Industries Ltd.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 Research & Development Expenses
- 8.10.5 Recent strategies and developments:
  - 8.10.5.1 Product Launches and Product Expansions:
- 8.10.6 SWOT Analysis

LIST OF TABLES

TABLE 1 LAMEA Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 4 LAMEA Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 5 LAMEA Allergic Conjunctivitis Market, by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Allergic Conjunctivitis Market, by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Viral Conjunctivitis Market, by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Viral Conjunctivitis Market, by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Bacterial Conjunctivitis Market, by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Bacterial Conjunctivitis Market, by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 12 LAMEA Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 13 LAMEA Anti-allergic Market, by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Anti-allergic Market, by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Antiviral Market, by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Antiviral Market, by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Artificial Tears Market, by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Artificial Tears Market, by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Antibiotics Market, by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Antibiotics Market, by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 LAMEA Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 23 LAMEA Hospital Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Hospital Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Retail Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Retail Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Online Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Online Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Conjunctivitis Treatment Market, by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Conjunctivitis Treatment Market, by Country, 2023 - 2030, USD Million
TABLE 31 Brazil Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 32 Brazil Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 33 Brazil Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 34 Brazil Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 35 Brazil Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 36 Brazil Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 37 Brazil Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 38 Brazil Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 39 Argentina Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 40 Argentina Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 41 Argentina Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 42 Argentina Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 43 Argentina Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 44 Argentina Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 45 Argentina Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Argentina Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 UAE Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 48 UAE Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 49 UAE Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 50 UAE Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 51 UAE Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 52 UAE Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 53 UAE Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 UAE Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 Saudi Arabia Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 56 Saudi Arabia Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 57 Saudi Arabia Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 59 Saudi Arabia Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 60 Saudi Arabia Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 61 Saudi Arabia Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 63 South Africa Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 64 South Africa Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 65 South Africa Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 66 South Africa Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 67 South Africa Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 68 South Africa Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 69 South Africa Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 South Africa Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 71 Nigeria Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 72 Nigeria Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 73 Nigeria Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 74 Nigeria Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 75 Nigeria Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 76 Nigeria Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 77 Nigeria Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 78 Nigeria Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 79 Rest of LAMEA Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 80 Rest of LAMEA Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 81 Rest of LAMEA Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 83 Rest of LAMEA Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 84 Rest of LAMEA Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 85 Rest of LAMEA Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 86 Rest of LAMEA Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 87 Key Information - Novartis AG
TABLE 88 Key Information - Gilead Sciences, Inc.
TABLE 89 Key Information - GlaxoSmithKline PLC
TABLE 90 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 91 Key Information - Merck & Co., Inc.
TABLE 92 Key Information - Boehringer Ingelheim International GmbH
TABLE 93 Key information - AbbVie, Inc.
TABLE 94 Key Information - AFT Pharmaceuticals
TABLE 95 key information - Bausch Health Companies, Inc.
TABLE 96 Key Information - Teva Pharmaceuticals Industries Ltd.

LAMEA Conjunctivitis Treatment Market Size, Share & Trends Analysis Report By Disease Type, By Drug Class (Anti-allergic, Antiviral, Artificial Tears, and Antibiotics), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents